|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-3-30
|
|
pubmed:abstractText |
To determine the safety and efficacy of preoperative hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) and an incorporated boost with concurrent capecitabine in patients with locally advanced rectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
pubmed-author:CallahanElaineE,
pubmed-author:ChengJonathanJ,
pubmed-author:CohenSteveS,
pubmed-author:FreedmanGary MGM,
pubmed-author:HoffmanJohnJ,
pubmed-author:KonskiAndreA,
pubmed-author:MeropolNeal JNJ,
pubmed-author:PriceRobertR,
pubmed-author:RogatkoAndréA,
pubmed-author:SigurdsonElin RER,
pubmed-author:StanT CTC,
pubmed-author:Watkins-BrunerDeborahD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1389-93
|
|
pubmed:meshHeading |
pubmed-meshheading:17394942-Aged,
pubmed-meshheading:17394942-Antimetabolites, Antineoplastic,
pubmed-meshheading:17394942-Combined Modality Therapy,
pubmed-meshheading:17394942-Deoxycytidine,
pubmed-meshheading:17394942-Dose Fractionation,
pubmed-meshheading:17394942-Female,
pubmed-meshheading:17394942-Fluorouracil,
pubmed-meshheading:17394942-Humans,
pubmed-meshheading:17394942-Intraoperative Period,
pubmed-meshheading:17394942-Male,
pubmed-meshheading:17394942-Maximum Tolerated Dose,
pubmed-meshheading:17394942-Middle Aged,
pubmed-meshheading:17394942-Photons,
pubmed-meshheading:17394942-Quality of Life,
pubmed-meshheading:17394942-Radiotherapy, Intensity-Modulated,
pubmed-meshheading:17394942-Rectal Neoplasms
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19111, USA. G_Freedman@FCCC.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
